Imprimis Pharmaceuticals, Inc.
(NASDAQ : IMMY)

( )
IMMY After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
0.50%66.8622.0%$201.05m
ZGNXZogenix, Inc.
1.67%39.6516.8%$134.04m
SHPGShire PLC Sponsored ADR
1.05%147.820.4%$131.58m
VRXValeant Pharmaceuticals International, Inc.
0.69%12.4814.2%$115.17m
PRGOPerrigo Co. Plc
-1.24%87.456.5%$92.40m
AERIAerie Pharmaceuticals, Inc.
0.62%64.858.6%$65.23m
MNKMallinckrodt Plc
2.05%32.8217.7%$56.91m
CTLTCatalent Inc
1.23%42.682.7%$56.83m
JAZZJazz Pharmaceuticals Plc
3.23%145.002.2%$54.11m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.58%109.407.6%$49.32m
UTHRUnited Therapeutics Corporation
-0.88%119.0614.4%$45.49m
ENDPEndo International Plc
3.01%7.888.9%$41.77m
PTLAPortola Pharmaceuticals, Inc.
0.36%50.477.9%$41.55m
HZNPHorizon Pharma plc
2.24%14.147.6%$35.30m
MDCOMedicines Company
-0.26%34.4522.1%$34.68m

Company Profile

Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.